Co-sponsored Seminar

Morning Seminar

Morning Seminar 1June 17, 2022 08:00-08:50 (Track 1)

The Future in IBD with Cutting Edge Technologies

Chair Kazuo Ohtsuka (Endoscopy, Tokyo Medical and Dental University Hospital)
Speaker
Usefulness of AI-assisted Endoscopy for UC
Yasuharu Maeda (Digestive Disease Center, Showa University Northern Yokohama Hospital)
 
Potential of New IEE for Activity Assessment in UC
Kaoru Takabayashi (Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine)
Co-sponsored by OLYMPUS MARKETING, INC.

Morning Seminar 2June 17, 2022 08:00-08:50 (Track 2)

IBD New Topics in Japan

Chair Ryuichi Okamoto (Tokyo Medical and Dental University, Tokyo, Japan)
Speaker
IBD Monitoring Topics
Kento Takenaka (Tokyo Medical and Dental University, Tokyo, Japan)
 
UC Treatment Topics
Taku Kobayashi (Kitasato University Kitasato Institute Hospital, Tokyo, Japan)
Co-sponsored by EA Pharma Co., Ltd. / SEKISUI MEDICAL CO., LTD.

Morning Seminar 3June 18, 2022 08:00-08:50 (Track 1)

Chair Haruhiko Ogata (Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine)
Speaker
Recent topics in ulcerative colitis 〜the new era of biosimilar
Jun Kato (Department of Gastroenterology, Graduate School of Medicine, Chiba University)
Co-sponsored by DAIICHI SANKYO COMPANY, LIMITED

Morning Seminar 4June 18, 2022 08:00-08:50 (Track 2)

Aiming at proper use of 5-ASA preparations for IBD management

Chair Atsushi Mizoguchi (Department of Immunology in Kurume University School of Medicine)
Speaker
Optimization of mesalazine treatment with fecal calprotectin in ulcerative colitis
Takayuki Yamamoto (IBD Center, Yokkaichi Hazu Medical Center)
 
Significance of 5-ASA therapy for Crohn’s disease
Ken Sugimoto (First Department of Medicine, Hamamatsu University of School of Medicine)
Co-sponsored by KYORIN Pharmaceutical Co., Ltd

Luncheon Seminar

Luncheon Seminar 1June 17, 2022 12:00-12:50 (Track 1)

Update on the efficacy and safety of Tofacitinib in the treatment of ulcerative colitis

Chair Hiroshi Nakase (Department of Gastroenterology and Hepatology Sapporo Medical University School of Medicine)
Speaker
Efficacy of tofacitinib
Taku Kobayashi (Center for Advanced IBD Research and Treatment Co-director, Department of Gastroenterology Kitasato University Kitasato Institute Hospital)
 
Update on the safety of tofacitinib
Katsuyoshi Matsuoka (Department of Gastroenterology Toho University Sakura Medical Center)
Co-sponsored by Pfizer Japan Inc.
Luncheon Seminar 1

Luncheon Seminar 2June 17, 2022 12:00-12:50 (Track 2)

Chair Mamoru Watanabe (Vice President,Tokyo Medical and Dental University)
Speaker
Recent Advances in Non-invasive Monitoring Tools to Achieve Treatment Targets for IBD
Shinichiro Shinzaki (Associate Professor,Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine)
Co-sponsored by Janssen Pharmaceutical K.K. / Mitsubishi Tanabe Pharma Corporation
Luncheon Seminar 2

Luncheon Seminar 3June 17, 2022 12:00-12:50 (Track 3)

Chair Tadakazu Hisamatsu (Professor, Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Speaker
Potential of New JAK Inhibitor and Strategy of Treatment in Patients with UC
Masayuki Saruta (Chairman and Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine,The Jikei University School of Medicine)
Co-sponsored by Gilead Sciences K.K. / EA Pharma Co., Ltd.

Luncheon Seminar 4June 18, 2022 12:00-12:50 (Track 1)

Chair Toshifumi Hibi (Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital)
Speaker
Intestinal ultrasound for monitoring IBD
Jiro Hata (Dept. of Clinical Pathology (Endoscopy and Ultrasound), Kawasaki Medical School)
 
Introduction of intestinal ultrasound for IBD in daily practice 
Jun Miyoshi (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Co-sponsored by AbbVie GK Medical Affairs

Luncheon Seminar 5June 18, 2022 12:00-12:50 (Track 2)

Small Bowel CD Management: Making a big impact on patient outcomes

Chair Haruhiko Ogata (Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine JAPAN)
Speaker
A paradigm shift in the management of small bowel CD
Marla DUBINSKY (Division of Pediatric Gastroenterology at Mount Sinai Kravis Children’s Hospital Susan and Leonard Feinstein Clinical IBD Center, USA)
 
Diagnosis and management of small bowel CD
Masano NAKAMURA (Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine, Aichi JAPAN)
Co-sponsored by Janssen Asia Pacific

Luncheon Seminar 6June 18, 2022 12:00-12:50 (Track 3)

Chair Mamoru Watanabe (Tokyo Medical and Dental University Vice President / Academic Advisor)
Speaker
Regenerative Medicine in IBD
Ryuichi Okamoto (Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University )
Co-sponsored by MIYARISAN PHARMACEUTICAL CO., LTD.

Evening Seminar

Evening Seminar 1June 17, 2022 17:30-18:20 (Track 1)

Chair Takanori Kanai (Professor, Division of Gastroenterology & Hepatology, Department of Internal Medicine Keio University School of Medicine, Tokyo, Japan)
Speaker
How is IBD pathophysiology relevant to current therapy?
Iris Dotan (Director, Division of Gastroenterology, Rabin Medical Center Petah Tikva , Israel and the Sackler Faculty of Medicine, Tel Aviv University, Israel)
Co-sponsored by Takeda Pharmaceutical Company Limited

Evening Seminar 2June 17, 2022 17:30-18:20 (Track 3)

Chair Toshifumi Hibi (Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital)
Speaker
Best evidence to answer the clinical question of GMA treatment for Ulcerative colitis
Tadakazu Hisamatsu (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Co-sponsored by JIMRO Co., Ltd.